Lim V S, Bier D M, Flanigan M J, Sum-Ping S T
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242.
J Clin Invest. 1993 Jun;91(6):2429-36. doi: 10.1172/JCI116477.
To assess the effect of hemodialysis on protein metabolism, leucine flux was measured in seven patients before, during, and after high efficiency hemodialysis using cuprophane dialyzers and bicarbonate dialysate during a primed-constant infusion of L-[1-13C]leucine. The kinetics [mumol/kg per h, mean +/- SD] are as follows: leucine appearance into the plasma leucine pool was 86 +/- 28, 80 +/- 28, and 85 +/- 25, respectively, before, during, and after dialysis. Leucine appearance into the whole body leucine pool, derived from plasma [1-13C]alpha-ketoisocaproate enrichment, was 118 +/- 31, 118 +/- 31, and 114 +/- 28 before, during, and after dialysis, respectively. In the absence of leucine intake, appearance rate reflects protein degradation, which was clearly unaffected by dialysis. Leucine oxidation rate was 17.3 +/- 7.8 before, decreased to 13.8 +/- 7.8 during, and increased to 18.9 +/- 10.3 after dialysis (P = 0.027). Leucine protein incorporation was 101 +/- 26 before, was reduced to 89 +/- 23 during, and returned to 95 +/- 23 after dialysis (P = 0.13). Leucine net balance, the difference between leucine protein incorporation and leucine release from endogenous degradation, was -17.3 +/- 7.8 before, decreased to -28.5 +/- 11.0 during, and returned to -18.9 +/- 10.3 after dialysis (P < 0.0001). This markedly more negative leucine balance during dialysis was accountable by dialysate leucine loss, which was 14.4 +/- 6.2 mumol/kg per h. These data suggest that hemodialysis using a cuprophane membrane did not acutely induce protein degradation. It was, nevertheless, a net catabolic event because protein synthesis was reduced and amino acid was lost into the dialysate.
为评估血液透析对蛋白质代谢的影响,在7例患者中,于高效血液透析前、透析期间及透析后,使用铜仿膜透析器和碳酸氢盐透析液,在L-[1-13C]亮氨酸的预充 - 持续输注过程中测量亮氨酸通量。动力学参数[μmol/kg每小时,均值±标准差]如下:透析前、透析期间及透析后,亮氨酸进入血浆亮氨酸池的速率分别为86±28、80±28和85±25。根据血浆[1-13C]α-酮异己酸富集情况得出,亮氨酸进入全身亮氨酸池的速率在透析前、透析期间及透析后分别为118±31、118±31和114±28。在无亮氨酸摄入的情况下,亮氨酸的生成速率反映蛋白质降解,显然不受透析影响。亮氨酸氧化速率在透析前为17.3±7.8,透析期间降至13.8±7.8,透析后升至18.9±10.3(P = 0.027)。亮氨酸整合入蛋白质的速率在透析前为101±26,透析期间降至89±23,透析后恢复至95±23(P = 0.13)。亮氨酸净平衡,即亮氨酸整合入蛋白质与内源性降解释放的亮氨酸之间的差值,在透析前为 -17.3±7.8,透析期间降至 -28.5±11.0,透析后恢复至 -18.9±10.3(P < 0.0001)。透析期间亮氨酸平衡显著更负是由于透析液中亮氨酸丢失所致,丢失速率为14.4±6.2 μmol/kg每小时。这些数据表明,使用铜仿膜进行血液透析不会急性诱导蛋白质降解。然而,这仍是一个净分解代谢事件,因为蛋白质合成减少且氨基酸丢失到透析液中。